{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:45:26Z","timestamp":1787507126173,"version":"build-2736575974"},"reference-count":54,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Inflammatory Bowel Diseases (IBD), most notably ulcerative colitis (UC) and Crohn\u2019s disease (CD), are long-standing disorders driven by dysregulated immune responses within the gastrointestinal tract and characterized by several metabolic disturbances, which are believed to influence disease progression. We have recently shown that a systemic deficiency of taurine, a semi-essential amino acid with anti-inflammatory properties, marks IBD. To characterize the temporal dynamics and determinants of taurine deficiency in IBD, we conducted a prospective longitudinal study assessing serum taurine levels in a cohort of 47 patients with IBD compared with 33 healthy controls. Serum taurine concentrations were measured at baseline and after a median follow-up period of 45 months using ELISA. Patients were stratified by disease subtype (UC and CD), age group, and clinical activity status at baseline and follow-up. Serum taurine levels were significantly lower in IBD patients at both baseline and the end of follow-up (p &lt; 0.05), and remained stable over time within the CD and UC cohorts. In healthy individuals, but not in IBD patients, taurine concentrations declined with age, suggesting that age-related metabolic regulation of taurine is altered in the context of chronic intestinal inflammation. Stratification by disease activity revealed that taurine deficiency was present in both active and inactive IBD, particularly among younger patients, and differences between active and inactive disease were minimal. These findings indicate that the persistent reduction in serum taurine in IBD is independent of age, disease subtype, or clinical activity, and remains relatively constant over time across most patient subgroups, suggesting an underlying alteration in taurine metabolism or homeostasis associated with IBD pathophysiology. Further investigation is needed to elucidate the mechanisms linking taurine dysregulation to IBD progression.<\/jats:p>","DOI":"10.3390\/ijms27020725","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:13:01Z","timestamp":1768209181000},"page":"725","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Longitudinal Evidence of Sustained Taurine Deficiency in Inflammatory Bowel Disease"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7866-7099","authenticated-orcid":false,"given":"Rachele","family":"Frascatani","sequence":"first","affiliation":[{"name":"Department of Systems Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaide","family":"Mattogno","sequence":"additional","affiliation":[{"name":"Policlinico Universitario \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4980-6289","authenticated-orcid":false,"given":"Silvia","family":"Salvatori","sequence":"additional","affiliation":[{"name":"Policlinico Universitario \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5194-8959","authenticated-orcid":false,"given":"Andrea","family":"Iannucci","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Marafini","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"},{"name":"Policlinico Universitario \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1339-9076","authenticated-orcid":false,"given":"Giovanni","family":"Monteleone","sequence":"additional","affiliation":[{"name":"Department of Systems Medicine, University of Rome \u201cTor Vergata\u201d, 00133 Rome, Italy"},{"name":"Policlinico Universitario \u201cTor Vergata\u201d, 00133 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.4049\/jimmunol.1302238","article-title":"Plasma Cells in the Mucosa of Patients with Inflammatory Bowel Disease Produce Granzyme B and Possess Cytotoxic Activities","volume":"192","author":"Cupi","year":"2014","journal-title":"J. Immunol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1093\/ibd\/izaf225","article-title":"Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Pathophysiology to Precision Therapeutics","volume":"31","author":"Selvakumar","year":"2025","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Monteleone, G., Calisi, C., Salvatori, S., and Marafini, I. (2025). Fundamental and Emerging Insights into Innate and Adaptive Immunity in Inflammatory Bowel Diseases. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1665530"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/gut.43.6.735","article-title":"Interleukin 12 and Th1 Responses in Inflammatory Bowel Disease","volume":"43","author":"Pallone","year":"1998","journal-title":"Gut"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Baum, S., Hamedi, K., Loftus, C., Loftus, G., Zhou, E.-R., and Arce, S. (2025). From Cytokines to Biomarkers: Mapping the Immunopathology of Inflammatory Bowel Disease. Cells, 14.","DOI":"10.3390\/cells14201589"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"jjaf061","DOI":"10.1093\/ecco-jcc\/jjaf061","article-title":"Gene-Environment Interactions in Inflammatory Bowel Disease: A Systematic Review of Human Epidemiologic Studies","volume":"19","author":"Bai","year":"2025","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Wang, Q., Meng, Q., Chen, Y., Liu, Y., Li, X., Zhou, J., Ma, Y., Yu, Z., and Chen, X. (2025). Interaction between Gut Microbiota and Immunity in Health and Intestinal Disease. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1673852"},{"key":"ref_8","first-page":"398","article-title":"Gut Microbiome in IBD: Past, Present and the Future","volume":"75","author":"Zhang","year":"2026","journal-title":"Gut"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/ecco-jcc\/jjw139","article-title":"Sodium Chloride\u2013Enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice","volume":"11","author":"Monteleone","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"103410","DOI":"10.1016\/j.autrev.2023.103410","article-title":"Immune-Mediated Inflammatory Diseases: Common and Different Pathogenic and Clinical Features","volume":"22","author":"Monteleone","year":"2023","journal-title":"Autoimmun. Rev."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Dylgjeri, S., Bartoszek, E.M., Hruz, P., Melhem, H., and Niess, J.H. (Mucosal Immunol., 2025). Cytochrome P450 Cyp2s1 Regulation of the Intestinal Metabolome and Microbiome, Mucosal Immunol., in press.","DOI":"10.1016\/j.mucimm.2025.10.007"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e09073","DOI":"10.1002\/advs.202509073","article-title":"Secondary Bile Acids Modified by Odoribacter splanchnicus Alleviate Colitis by Suppressing Neutrophil Extracellular Trap Formation","volume":"12","author":"Xu","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2546998","DOI":"10.1080\/19490976.2025.2546998","article-title":"Metabolomics Reveal Distinct Molecular Pathways Associated with Future Risk of Crohn\u2019s Disease","volume":"17","author":"Xue","year":"2025","journal-title":"Gut Microbes"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Frascatani, R., Mattogno, A., Iannucci, A., Marafini, I., and Monteleone, G. (2024). Reduced Taurine Serum Levels in Inflammatory Bowel Disease. Nutrients, 16.","DOI":"10.3390\/nu16111593"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00726-007-0562-8","article-title":"Attenuation by Dietary Taurine of Dextran Sulfate Sodium-Induced Colitis in Mice and of THP-1-Induced Damage to Intestinal Caco-2 Cell Monolayers","volume":"35","author":"Zhao","year":"2008","journal-title":"Amino Acids"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0378-1097(03)00611-6","article-title":"Taurine: New Implications for an Old Amino Acid","volume":"226","author":"Park","year":"2003","journal-title":"FEMS Microbiol. Lett."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1023\/B:NERE.0000010440.37629.17","article-title":"Taurine and Its Chloramine: Modulators of Immunity","volume":"29","author":"Park","year":"2004","journal-title":"Neurochem. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"12119","DOI":"10.1021\/acs.jafc.4c00662","article-title":"Taurine Alleviates Experimental Colitis by Enhancing Intestinal Barrier Function and Inhibiting Inflammatory Response through TLR4\/NF-\u03baB Signaling","volume":"72","author":"Zheng","year":"2024","journal-title":"J. Agric. Food Chem."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Santulli, G., Kansakar, U., Varzideh, F., Mone, P., Jankauskas, S.S., and Lombardi, A. (2023). Functional Role of Taurine in Aging and Cardiovascular Health: An Updated Overview. Nutrients, 15.","DOI":"10.3390\/nu15194236"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"eabn9257","DOI":"10.1126\/science.abn9257","article-title":"Taurine Deficiency as a Driver of Aging","volume":"380","author":"Singh","year":"2023","journal-title":"Science"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00726-015-2155-2","article-title":"Taurine Content in Different Brain Structures during Ageing: Effect on Hippocampal Synaptic Plasticity","volume":"48","year":"2016","journal-title":"Amino Acids"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00726-021-02956-2","article-title":"Age-Related Decline in the Taurine Content of the Skin in Rodents","volume":"53","author":"Yoshimura","year":"2021","journal-title":"Amino Acids"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Iyer, N., and Corr, S.C. (2021). Gut Microbial Metabolite-Mediated Regulation of the Intestinal Barrier in the Pathogenesis of Inflammatory Bowel Disease. Nutrients, 13.","DOI":"10.3390\/nu13124259"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut Microbiota-Derived Metabolites as Key Actors in Inflammatory Bowel Disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s41232-024-00321-w","article-title":"Metabolic Network of the Gut Microbiota in Inflammatory Bowel Disease","volume":"44","author":"Sugihara","year":"2024","journal-title":"Inflamm. Regen."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gu, B.-H., Kim, M., and Yun, C.-H. (2021). Regulation of Gastrointestinal Immunity by Metabolites. Nutrients, 13.","DOI":"10.3390\/nu13010167"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s00109-023-02381-w","article-title":"Interaction between Mitochondria and Microbiota Modulating Cellular Metabolism in Inflammatory Bowel Disease","volume":"101","author":"Hirose","year":"2023","journal-title":"J. Mol. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.aninu.2020.11.003","article-title":"Mutual Interaction between Gut Microbiota and Protein\/Amino Acid Metabolism for Host Mucosal Immunity and Health","volume":"7","author":"Wu","year":"2021","journal-title":"Anim. Nutr."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"9171905","DOI":"10.1155\/2018\/9171905","article-title":"Functions and Signaling Pathways of Amino Acids in Intestinal Inflammation","volume":"2018","author":"He","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/1541-4337.12401","article-title":"Dietary Amino Acids and the Gut-Microbiome-Immune Axis: Physiological Metabolism and Therapeutic Prospects","volume":"18","author":"Ma","year":"2019","journal-title":"Comp. Rev. Food Sci. Food Saf."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"100227","DOI":"10.1016\/j.cellin.2025.100227","article-title":"The Role of Colonic Microbiota Amino Acid Metabolism in Gut Health Regulation","volume":"4","author":"Chen","year":"2025","journal-title":"Cell Insight"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"7363","DOI":"10.1038\/s41467-023-43211-4","article-title":"Dietary L-Tryptophan Consumption Determines the Number of Colonic Regulatory T Cells and Susceptibility to Colitis via GPR15","volume":"14","author":"Van","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/gutjnl-2022-327337","article-title":"Rewiring the Altered Tryptophan Metabolism as a Novel Therapeutic Strategy in Inflammatory Bowel Diseases","volume":"72","author":"Michaudel","year":"2023","journal-title":"Gut"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/MOG.0b013e328352ad69","article-title":"The Aryl Hydrocarbon Receptor in Inflammatory Bowel Disease: Linking the Environment to Disease Pathogenesis","volume":"28","author":"Monteleone","year":"2012","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/ibd.21849","article-title":"Serum Analysis of Tryptophan Catabolism Pathway: Correlation with Crohn\u2019s Disease Activity","volume":"18","author":"Gupta","year":"2012","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Wang, S., Van Schooten, F.-J., Jin, H., Jonkers, D., and Godschalk, R. (2023). The Involvement of Intestinal Tryptophan Metabolism in Inflammatory Bowel Disease Identified by a Meta-Analysis of the Transcriptome and a Systematic Review of the Metabolome. Nutrients, 15.","DOI":"10.3390\/nu15132886"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2017.08.028","article-title":"Increased Tryptophan Metabolism Is Associated with Activity of Inflammatory Bowel Diseases","volume":"153","author":"Nikolaus","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.immuni.2024.06.010","article-title":"Antibiotic-Driven Dysbiosis in Early Life Disrupts Indole-3-Propionic Acid Production and Exacerbates Allergic Airway Inflammation in Adulthood","volume":"57","author":"Perdijk","year":"2024","journal-title":"Immunity"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wisniewski, P.J., Nagarkatti, M., and Nagarkatti, P.S. (2021). Regulation of Intestinal Stem Cell Stemness by the Aryl Hydrocarbon Receptor and Its Ligands. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.638725"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Surai, P.F., Earle-Payne, K., and Kidd, M.T. (2021). Taurine as a Natural Antioxidant: From Direct Antioxidant Effects to Protective Action in Various Toxicological Models. Antioxidants, 10.","DOI":"10.3390\/antiox10121876"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s00726-011-0962-7","article-title":"Mechanism Underlying the Antioxidant Activity of Taurine: Prevention of Mitochondrial Oxidant Production","volume":"42","author":"Jong","year":"2012","journal-title":"Amino Acids"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/978-1-4899-0117-0_37","article-title":"Taurine Can Ameliorate Inflammatory Bowel Disease in Rats","volume":"Volume 442","author":"Schaffer","year":"1998","journal-title":"Taurine 3; Advances in Experimental Medicine and Biology"},{"key":"ref_43","first-page":"630","article-title":"Reduced Plasma Taurine Level in Parkinson\u2019s Disease: Association with Motor Severity and Levodopa Treatment","volume":"126","author":"Zhang","year":"2016","journal-title":"Int. J. Neurosci."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Sak, D., Erdenen, F., M\u00fcderrisoglu, C., Altunoglu, E., Sozer, V., Gungel, H., Guler, P.A., Sak, T., and Uzun, H. (2019). The Relationship between Plasma Taurine Levels and Diabetic Complications in Patients with Type 2 Diabetes Mellitus. Biomolecules, 9.","DOI":"10.3390\/biom9030096"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12986-022-00684-2","article-title":"Protective and Therapeutic Effectiveness of Taurine Supplementation plus Low Calorie Diet on Metabolic Parameters and Endothelial Markers in Patients with Diabetes Mellitus: A Randomized, Clinical Trial","volume":"19","author":"Moludi","year":"2022","journal-title":"Nutr. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.2000.7591","article-title":"Depletion of Taurine in Experimental Diabetic Neuropathy: Implications for Nerve Metabolic, Vascular, and Functional Deficits","volume":"168","author":"Sullivan","year":"2001","journal-title":"Exp. Neurol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1423-0127-17-S1-S4","article-title":"Taurine and the Renal System","volume":"17","author":"Chesney","year":"2010","journal-title":"J. Biomed. Sci."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/ki.1996.490","article-title":"Evidence of Taurine Depletion and Accumulation of Cysteinesulfinic Acid in Chronic Dialysis Patients","volume":"50","author":"Suliman","year":"1996","journal-title":"Kidney Int."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Abbasian, N., Ghaderi-Najafabadi, M., Watson, E., Brown, J., Yu Si, L., Bursnall, D., Pawluczyk, I., Seymour, A.-M., and Bevington, A. (2021). Hepatic Cysteine Sulphinic Acid Decarboxylase Depletion and Defective Taurine Metabolism in a Rat Partial Nephrectomy Model of Chronic Kidney Disease. BMC Nephrol., 22.","DOI":"10.1186\/s12882-021-02442-7"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41430-021-01010-4","article-title":"Profiling Inflammatory and Oxidative Stress Biomarkers Following Taurine Supplementation: A Systematic Review and Dose-Response Meta-Analysis of Controlled Trials","volume":"76","author":"Faghfouri","year":"2022","journal-title":"Eur. J. Clin. Nutr."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00805717","article-title":"Taurine: A Therapeutic Agent in Experimental Kidney Disease","volume":"11","author":"Trachtman","year":"1996","journal-title":"Amino Acids"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0167-5273(90)90293-E","article-title":"Significance of Blood Taurine Levels in Patients with First Time Acute Ischaemic Cardiac Pain","volume":"27","author":"Bhatnagar","year":"1990","journal-title":"Int. J. Cardiol."},{"key":"ref_53","first-page":"849","article-title":"Elevated Blood Taurine Levels in Acute and Evolving Myocardial Infarction","volume":"98","author":"Lombardini","year":"1981","journal-title":"J. Lab. Clin. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1038\/s41423-025-01344-0","article-title":"Intestinal Taurine Acts as a Novel Immunometabolic Modulator of IBD by Degrading Redundant Mitochondrial RNA","volume":"22","author":"Wu","year":"2025","journal-title":"Cell. Mol. Immunol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/725\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T09:17:15Z","timestamp":1768209435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/2\/725"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":54,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["ijms27020725"],"URL":"https:\/\/doi.org\/10.3390\/ijms27020725","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]}}}